Jazmin Calyeca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jazmin Calyeca has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Lumei Liu
Center of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, USA
3 shared publications - Tendy Chiang
Center for Regenerative Medicine Abigail Wexner Research Institute, Nationwide Children's Hospital Columbus Ohio USA
3 shared publications Ada C. Sher
The Ohio State University College of Medicine Columbus Ohio USA
1 shared publication- Ada Cleary Sher
The Ohio State University College of Medicine, Columbus, OH, USA
1 shared publication - Ana Lucia Mora
Ohio State University
1 shared publication - Andrea Nachón-Acosta
Experimental Lung Transplant Unit of the Department of Experimental Surgery, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 15 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (9) , 3895-3906
Endothelial Hydrogels Improve Microvascular Regeneration and Perfusion in Tracheal Scaffolds
Objective: Vascularization remains a major barrier to the clinical translation of airway replacement. We previously demonstrated that engineered tracheal scaffolds support neovascularization, although restoration of microvascular perfusion is delayed in part due to a reduction in capillary branching. Endothelial hydrogels (EH) have demonstrated the potential to enhance vascular regeneration in several domains of tissue engineering, yet their application in airway replacement has not been fully evaluated. In this study, we assessed the impact of EH on microvascular regeneration and perfusion in tracheal scaffolds. Methods: Tracheal scaffolds were fabricated from C57BL/6J mice. EH were formulated with endothelial cells (EC) from human or mouse lineages and collagen, then applied to tracheal scaffolds. EH‐scaffolds were cultured ex vivo for 7 days and stained with CD31, DAPI, lectin‐FITC, and vascular endothelial growth factor (VEGF). The optimal EH composition was evaluated in vivo using orthotopic tracheal transplantation. At 1‐month, microvascular regeneration was quantified, patterning was assessed via Sholl analysis, and perfusion was quantified using lectin‐FITC. Results: EH supported EC attachment on tracheal scaffolds. The ideal EH composition for maximal EC coverage was 3.6 × 10 6 cells/cm 2 and 1.25 mg/mL collagen. EC expressed VEGF and formed microvascular networks on tracheal scaffold ex vivo. EH‐scaffolds were successfully implanted without signs of respiratory distress or obstruction. Compared to control, EH‐scaffolds improved graft perfusion and microvascular patterning in tissue engineered trachea. Conclusion: EH enhances microvascular regeneration and perfusion of engineered tracheal scaffolds in vivo, thus supporting the potential of EH as a strategy to accelerate vascular regeneration in airway reconstruction. Level of Evidence: N/A.
- 15 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (9) , 3895-3906
Open AccessEndothelial Hydrogels Improve Microvascular Regeneration and Perfusion in Tracheal Scaffolds
Objective: Vascularization remains a major barrier to the clinical translation of airway replacement. We previously demonstrated that engineered tracheal scaffolds support neovascularization, although restoration of microvascular perfusion is delayed in part due to a reduction in capillary branching. Endothelial hydrogels (EH) have demonstrated the potential to enhance vascular regeneration in several domains of tissue engineering, yet their application in airway replacement has not been fully evaluated. In this study, we assessed the impact of EH on microvascular regeneration and perfusion in tracheal scaffolds. Methods: Tracheal scaffolds were fabricated from C57BL/6J mice. EH were formulated with endothelial cells (EC) from human or mouse lineages and collagen, then applied to tracheal scaffolds. EH‐scaffolds were cultured ex vivo for 7 days and stained with CD31, DAPI, lectin‐FITC, and vascular endothelial growth factor (VEGF). The optimal EH composition was evaluated in vivo using orthotopic tracheal transplantation. At 1‐month, microvascular regeneration was quantified, patterning was assessed via Sholl analysis, and perfusion was quantified using lectin‐FITC. Results: EH supported EC attachment on tracheal scaffolds. The ideal EH composition for maximal EC coverage was 3.6 × 10 6 cells/cm 2 and 1.25 mg/mL collagen. EC expressed VEGF and formed microvascular networks on tracheal scaffold ex vivo. EH‐scaffolds were successfully implanted without signs of respiratory distress or obstruction. Compared to control, EH‐scaffolds improved graft perfusion and microvascular patterning in tissue engineered trachea. Conclusion: EH enhances microvascular regeneration and perfusion of engineered tracheal scaffolds in vivo, thus supporting the potential of EH as a strategy to accelerate vascular regeneration in airway reconstruction. Level of Evidence: N/A.
- Open Access
- 2 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
12,13-diHOME protects against the age-related decline in cardiovascular function via attenuation of CaMKII
Aging poses significant challenges to cardiovascular health necessitating novel therapeutic approaches. This study investigates the potential of the brown adipose tissue (BAT) derived lipokine 12,13-diHOME to mitigate age-induced impairments in cardiovascular function. Analysis of human and rodent plasma signaling lipids reveals a decline in 12,13-diHOME levels with age. Transplantation of BAT or sustained upregulation of 12,13-diHOME effectively preserved cardiac function in aged male and female mice. Bulk RNA-Seq of hearts from aged mice reveals significant increases in pathways involved in ER stress and fibrosis which were partially attenuated by BAT transplantation or sustained upregulation of 12,13-diHOME. Mechanistically, in vivo and in vitro models demonstrate that 12,13-diHOME alleviated ER stress through CaMKII inhibition, particularly in males. These findings underscore 12,13-diHOME as a promising candidate for combating age-related cardiovascular dysfunction, offering insights into potential therapeutic strategies for addressing cardiovascular diseases in aging populations.
- 2 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open Access12,13-diHOME protects against the age-related decline in cardiovascular function via attenuation of CaMKII
Aging poses significant challenges to cardiovascular health necessitating novel therapeutic approaches. This study investigates the potential of the brown adipose tissue (BAT) derived lipokine 12,13-diHOME to mitigate age-induced impairments in cardiovascular function. Analysis of human and rodent plasma signaling lipids reveals a decline in 12,13-diHOME levels with age. Transplantation of BAT or sustained upregulation of 12,13-diHOME effectively preserved cardiac function in aged male and female mice. Bulk RNA-Seq of hearts from aged mice reveals significant increases in pathways involved in ER stress and fibrosis which were partially attenuated by BAT transplantation or sustained upregulation of 12,13-diHOME. Mechanistically, in vivo and in vitro models demonstrate that 12,13-diHOME alleviated ER stress through CaMKII inhibition, particularly in males. These findings underscore 12,13-diHOME as a promising candidate for combating age-related cardiovascular dysfunction, offering insights into potential therapeutic strategies for addressing cardiovascular diseases in aging populations.
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 614-621
Microvascular Regeneration and Perfusion of Partially Decellularized Tracheal Grafts
Objectives: A critical barrier to successful tracheal transplantation is poor vascularization. Despite its importance, little is known about microvascular regeneration in tissue‐engineered grafts. We have demonstrated that partially decellularized tracheal grafts (PDTG) support neotissue formation including new submucosal microvasculature (CD31+). However, the perfusion of this neovasculature is unknown. In this study, we used a mouse model of tracheal replacement to measure the microvascular regeneration and perfusion of PDTG.Methods: PDTG and syngeneic tracheal grafts (STG, surgical control) (n = 5 for each group) were orthotopically transplanted into C5BL/6 J mice. We quantified vascularity of STG and PDTG samples at 1 and 3 months with conventional histology (N = 3 ~ 10/group). At 1, 3, and 6 months, animals were injected with fluorescein isothiocyanate (FITC) tomato lectin into the left ventricle. After perfusion, tracheas were fixed, harvested, mounted, stained for CD31 expression, and imaged with resonant scanning confocal microscopy. Percent CD31+, FITC area was compared between groups and endpoints compared with native trachea. Microvascular intersections were quantified using Sholl analysis.Results: Functional microvasculature was seen in both groups. Although percent vascularization (CD31) in PDTG was restored by 3 months, microvascular pattern in PDTG displayed a unique morphology compared with control. Surgery alone appeared to globally change microvascular pattern and perfusion. PDTG demonstrated equivalent perfusion to surgical control by 6 months. Sholl analysis revealed a reduction of microvessel intersectionality that persisted in PDTG and was not seen in surgical or native controls.Conclusions: PDTG exhibited microvascular regeneration. Perfusion was present in PDTG, improved, and persisted over long‐term time points.Level of Evidence: NA Laryngoscope, 135:614–621, 2025
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (2) , 614-621
Microvascular Regeneration and Perfusion of Partially Decellularized Tracheal Grafts
Objectives: A critical barrier to successful tracheal transplantation is poor vascularization. Despite its importance, little is known about microvascular regeneration in tissue‐engineered grafts. We have demonstrated that partially decellularized tracheal grafts (PDTG) support neotissue formation including new submucosal microvasculature (CD31+). However, the perfusion of this neovasculature is unknown. In this study, we used a mouse model of tracheal replacement to measure the microvascular regeneration and perfusion of PDTG.Methods: PDTG and syngeneic tracheal grafts (STG, surgical control) (n = 5 for each group) were orthotopically transplanted into C5BL/6 J mice. We quantified vascularity of STG and PDTG samples at 1 and 3 months with conventional histology (N = 3 ~ 10/group). At 1, 3, and 6 months, animals were injected with fluorescein isothiocyanate (FITC) tomato lectin into the left ventricle. After perfusion, tracheas were fixed, harvested, mounted, stained for CD31 expression, and imaged with resonant scanning confocal microscopy. Percent CD31+, FITC area was compared between groups and endpoints compared with native trachea. Microvascular intersections were quantified using Sholl analysis.Results: Functional microvasculature was seen in both groups. Although percent vascularization (CD31) in PDTG was restored by 3 months, microvascular pattern in PDTG displayed a unique morphology compared with control. Surgery alone appeared to globally change microvascular pattern and perfusion. PDTG demonstrated equivalent perfusion to surgical control by 6 months. Sholl analysis revealed a reduction of microvessel intersectionality that persisted in PDTG and was not seen in surgical or native controls.Conclusions: PDTG exhibited microvascular regeneration. Perfusion was present in PDTG, improved, and persisted over long‐term time points.Level of Evidence: NA Laryngoscope, 135:614–621, 2025
- 14 May 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (9) , 4052-4059
Proteomic Analysis of Surgery‐induced Stress Post‐Tracheal Transplantation Highlights Changes in Matrisome
Objective: Investigate the impact of Surgery‐induced stress (SIS) on the normal airway repair process after airway reconstruction using a mouse microsurgery model, mass spectrometry (MS), and bioinformatic analysis.Methods: Tracheal tissue from non‐surgical (N = 3) and syngeneic tracheal grafts at 3 months post‐replacement (N = 3) were assessed using mass spectrometry. Statistical analysis was done using MASCOT via Proteome Discoverer™. Proteins were categorized into total, dysregulated, suppressed, and evoked proteins in response to SIS. Dysregulated proteins were identified using cut‐off values of −1 1 and t‐test (p value 2, p = 0.0003), despite reduced overall thickness (30 ± 3 μm, p = 0.01), compared to Native (4578 ± 723 cells/mm2; 42 ± 6 μm). Matrisome composition remained preserved, with proteomic analysis identifying 193 commonly abundant proteins, encompassing 7.2% collagens, 34.2% Extracellular matrix (ECM) glycoproteins, 6.2% proteoglycans, 33.2% ECM regulators, 14.5% Extracellular matrix‐affiliated, and 4.7% secreted factors. Additionally, our analysis unveiled a unique proteomic signature of 217 “Surgery‐evoked proteins” associated with SIS, revealing intricate connections among neutrophils, ECM remodeling, and vascularization through matrix metalloproteinase‐9 interaction.Conclusions: Our study demonstrated the impact of SIS on the extracellular matrix, particularly MMP9, after airway reconstruction. The novel identification of MMP9 prompts further investigation into its potential role in repair.Level of Evidence: NA Laryngoscope, 134:4052–4059, 2024
- 14 May 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (9) , 4052-4059
Proteomic Analysis of Surgery‐induced Stress Post‐Tracheal Transplantation Highlights Changes in Matrisome
Objective: Investigate the impact of Surgery‐induced stress (SIS) on the normal airway repair process after airway reconstruction using a mouse microsurgery model, mass spectrometry (MS), and bioinformatic analysis.Methods: Tracheal tissue from non‐surgical (N = 3) and syngeneic tracheal grafts at 3 months post‐replacement (N = 3) were assessed using mass spectrometry. Statistical analysis was done using MASCOT via Proteome Discoverer™. Proteins were categorized into total, dysregulated, suppressed, and evoked proteins in response to SIS. Dysregulated proteins were identified using cut‐off values of −1 1 and t‐test (p value 2, p = 0.0003), despite reduced overall thickness (30 ± 3 μm, p = 0.01), compared to Native (4578 ± 723 cells/mm2; 42 ± 6 μm). Matrisome composition remained preserved, with proteomic analysis identifying 193 commonly abundant proteins, encompassing 7.2% collagens, 34.2% Extracellular matrix (ECM) glycoproteins, 6.2% proteoglycans, 33.2% ECM regulators, 14.5% Extracellular matrix‐affiliated, and 4.7% secreted factors. Additionally, our analysis unveiled a unique proteomic signature of 217 “Surgery‐evoked proteins” associated with SIS, revealing intricate connections among neutrophils, ECM remodeling, and vascularization through matrix metalloproteinase‐9 interaction.Conclusions: Our study demonstrated the impact of SIS on the extracellular matrix, particularly MMP9, after airway reconstruction. The novel identification of MMP9 prompts further investigation into its potential role in repair.Level of Evidence: NA Laryngoscope, 134:4052–4059, 2024
- 1 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (7) , 1551-1561
Clinical, Histological, and Profibrotic Extracellular Matrix Protein Changes in a Model of Tracheal Stenosis Induced by Cervical Tracheal Autotransplantation
Tracheal stenosis (TS) is a complication of prolonged intubation, tracheotomy, and tracheal surgery that compromises the vascular supply. Animal models are essential for studying its pathophysiology and the effect of interventions. To establish a TS model in rats secondary to tracheal autotransplantation with a graft submerged in bleomycin (Atx-Bleo). Additionally, to evaluate the clinical and histological changes, as well as the expression of newly formed collagen (NFC), isoforms of transforming growth factor beta (TGFβ), fibronectin (FN), elastin (ELN), integrin β1 (ITGβ1), and matrix metalloproteinase 1 (MMP1) in TS. Twenty Wistar rats were divided into three groups: group I (n = 20) control; group II (n = 10) end-to-end anastomosis of the trachea (tracheoplasty); and group III (n = 10) Atx-Bleo. The animals were evaluated clinically, tomographically, macroscopically, morphometrically, and microscopically. NFC deposition, and the expression of profibrotic and antifibrotic proteins were evaluated in tracheal scars. All animals survived the surgical procedure and the study period. Compared with the other study groups, the Atx-Bleo group developed TS and fibrosis, exhibited higher expression of NFC, TGFβ1, TGFβ2, FN, ELN, and ITGβ1, and mild expression of TGFβ3 and MMP1 (p < 0.005; analysis of variance, Dunnett and Tukey tests). Atx-Bleo in TS model rats produces tomographic and histological changes, and induces the upregulation of profibrotic proteins (TGFβ1, TGFβ2, collagen, FN, ELN, ITGβ1) and downregulation of antifibrotic proteins (TGFβ3, MMP1). Therefore, this model may be used to test new pharmacological treatments for reversing or preventing TS, and conduct basic studies regarding its pathophysiology.
- 1 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (7) , 1551-1561
Clinical, Histological, and Profibrotic Extracellular Matrix Protein Changes in a Model of Tracheal Stenosis Induced by Cervical Tracheal Autotransplantation
Tracheal stenosis (TS) is a complication of prolonged intubation, tracheotomy, and tracheal surgery that compromises the vascular supply. Animal models are essential for studying its pathophysiology and the effect of interventions. To establish a TS model in rats secondary to tracheal autotransplantation with a graft submerged in bleomycin (Atx-Bleo). Additionally, to evaluate the clinical and histological changes, as well as the expression of newly formed collagen (NFC), isoforms of transforming growth factor beta (TGFβ), fibronectin (FN), elastin (ELN), integrin β1 (ITGβ1), and matrix metalloproteinase 1 (MMP1) in TS. Twenty Wistar rats were divided into three groups: group I (n = 20) control; group II (n = 10) end-to-end anastomosis of the trachea (tracheoplasty); and group III (n = 10) Atx-Bleo. The animals were evaluated clinically, tomographically, macroscopically, morphometrically, and microscopically. NFC deposition, and the expression of profibrotic and antifibrotic proteins were evaluated in tracheal scars. All animals survived the surgical procedure and the study period. Compared with the other study groups, the Atx-Bleo group developed TS and fibrosis, exhibited higher expression of NFC, TGFβ1, TGFβ2, FN, ELN, and ITGβ1, and mild expression of TGFβ3 and MMP1 (p < 0.005; analysis of variance, Dunnett and Tukey tests). Atx-Bleo in TS model rats produces tomographic and histological changes, and induces the upregulation of profibrotic proteins (TGFβ1, TGFβ2, collagen, FN, ELN, ITGβ1) and downregulation of antifibrotic proteins (TGFβ3, MMP1). Therefore, this model may be used to test new pharmacological treatments for reversing or preventing TS, and conduct basic studies regarding its pathophysiology.